Pursuant to the Provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kwality Pharmaceuticals has informed that the Company will held the Board meeting on Tuesday, 4th September, 2018 at 4.30 P.M. at the registered office of the company at VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR, Punjab-143601 to consider and approve the Report of Board of Directors under Section 134 of the Companies Act, 2013; to fix and approve the time, date & venue of the 35th Annual General Meeting of the Company; to consider & approve the Notice of the 35th Annual General Meeting to be sent to all the members of the Company; to fix and approve the dates of Book Closure for the purpose of 35th Annual General Meeting; and any other business as may deem necessary with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.20 |
| Dr. Reddys Lab | 1220.70 |
| Cipla | 1233.85 |
| Zydus Lifesciences | 931.20 |
| Lupin | 2307.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: